Evaluation of the SPINNER Device for the Application of Wound Dressing: Treatment of Split Skin Graft Donor Sites

Inclusion Criteria: * The patient is ≥ 18 years old at enrolment. Both genders. * Patients with donor site wound, size of 10-200 cm2, located in the thigh after partial thickness skin-graft * The patient is able and willing to comply with study procedures and give written informed consent prior to enrollment in the study Exclusion Criteria: * Any known or suspected systemic infection * Any known sensitivity to components/products used in this study * Use of penicillamine, corticosteroid or immunosuppressive medication within two months prior to enrollment, or current use of nonsteroidal anti- inflammatory agents which cannot be discontinued, or who is likely to be prescribed these medications or any other medications known to adversely affect wound healing during study participation * Major uncontrolled systemic disorders such as hepatic, renal, neurologic, or endocrinologic disorders. * Patients undergoing repeat skin graft harvesting at the same donor site * Patients with burns of more than 15% TBSA * Requires immersion hydrotherapy at any time during study participation * Bleeding disorders * Skin disorders such as psoriasis, pemphigus, Toxic Epidermal Necrolysis (TEN), Stevens-Johnson Syndrome (SJS), pyoderma gangrenosum and other exfoliative disorders * Terminal patients * Soldiers * Prisoners * Female patients who are pregnant or nursing, or of childbearing potential and are not using adequate contraception * Participation in another clinical trial within 30 days prior to the Screening Visit or during this study. * Psychiatric patient.